Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Meningioma × cabozantinib × Clear all

Sponsor

Conditions

Prostatic Neoplasms 13 Carcinoma, Renal Cell 12 Neoplasm Metastasis 7 Neoplasms 6 Carcinoma, Hepatocellular 5 Thyroid Neoplasms 4 Melanoma 4 Carcinoma, Non-Small-Cell Lung 4 Carcinoma, Medullary 4 Breast Neoplasms 4 Brain Neoplasms 4 Pancreatic Neoplasms 3 Neuroendocrine Tumors 3 Thyroid Cancer, Papillary 2 Small Cell Lung Carcinoma 2 Recurrence 2 Pain 2 Multiple Myeloma 2 Lung Neoplasms 2 Kidney Neoplasms 2 Glioma 2 Glioblastoma 2 Carcinoma, Transitional Cell 2 Carcinoma 2 Astrocytoma 2 Adenoma, Islet Cell 2 Adenocarcinoma, Follicular 2 Adenocarcinoma 2 Uveal Melanoma 1 Urinary Bladder Neoplasms 1

Interventions

Hydroxyurea 3 Bevacizumab 3 pembrolizumab 2 Imatinib Mesylate 2 Everolimus 2 vatalanib 1 pasireotide 1 fludarabine phosphate 1 fludarabine 1 arginyllysine 1 antineoplaston AS 2-1 1 antineoplaston A10 1 aldesleukin 1 Whole Body Imaging 1 Verapamil 1 Sunitinib 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Image-Guided 1 Radiotherapy, Conformal 1 Radiotherapy 1 Radiosurgery 1 Proton Therapy 1 Nivolumab 1 Modafinil 1 Magnetic Resonance Spectroscopy 1 Ipilimumab 1 Fentanyl 1 Erlotinib Hydrochloride 1 Donepezil 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡